Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (16735)	3/16/2004 12:08:08 PM
From: Bluegreen	Read Replies (1) \| Respond to of 17367

Bob, seems some may have forgotten just how risky it can be in Biotech!!!LOL Do you think FINALLY the last of the retail investors have been shaken out?LOL How many in the US suffer from acne?? Have you heard of XMP.629?????

To: Robert K. who wrote (16735)	3/21/2004 2:21:11 PM
From: Bluegreen	Respond to of 17367

Bob, just a reminder to the Dermatologists IF they are thinking of using Enbrel for their first line therapy go to drug for Psoriasis when Raptiva is available.>>>>>>>>http://www.rheingoldlaw.com/products/remicade_enbrel.html

To: Robert K. who wrote (16735)	3/22/2004 10:15:39 AM
From: Bluegreen	Respond to of 17367

How LOW can it go?????LOL

To: Robert K. who wrote (16735)	3/22/2004 10:59:04 AM
From: Bluegreen	Read Replies (1) \| Respond to of 17367

Bob, which would you rather have a HIGHLY SPECIFIC predictable and safe medication OR do you like the shotgun approach??? Just my opinions but I am AMAZED at how SPECIFIC Raptiva might be. Doesn't mean it doesn't have a possibility of being highly useful in other indications BUT I am once again AMAZED at how SPECIFIC Raptiva might be. Biologics like Raptiva are EXTREMELY RARE and of course VERY VALUABLE!!!!!!!!!!!!! Raptiva is truly a MIRACLE drug. I can't wait to see how all of this unfolds in the next several years.